These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9590746)
1. [Loss of p16 gene in bladder cancer and genitourinary carcinoma cell lines]. Guo D; Gu F; Zhou A Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):643-4. PubMed ID: 9590746 [TBL] [Abstract][Full Text] [Related]
2. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer. Tsutsumi M; Tsai YC; Gonzalgo ML; Nichols PW; Jones PA Oncogene; 1998 Dec; 17(23):3021-7. PubMed ID: 9881704 [TBL] [Abstract][Full Text] [Related]
3. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of bladder cancer: pathways of development and progression. Knowles MA Cancer Surv; 1998; 31():49-76. PubMed ID: 15281317 [No Abstract] [Full Text] [Related]
5. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression. Swellam M; El-Aal AA; AbuGabel KM Clin Biochem; 2004 Dec; 37(12):1098-104. PubMed ID: 15589816 [TBL] [Abstract][Full Text] [Related]
6. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours. Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer. Berggren de Verdier PJ; Kumar R; Adolfsson J; Larsson P; Norming U; Onelöv E; Wijkström H; Steineck G; Hemminki K Scand J Urol Nephrol; 2006; 40(5):363-9. PubMed ID: 17060081 [TBL] [Abstract][Full Text] [Related]
8. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma. Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304 [TBL] [Abstract][Full Text] [Related]
9. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines. van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858 [TBL] [Abstract][Full Text] [Related]
10. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis. Khaled HM; Aly MS; Mokhtar N Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858 [TBL] [Abstract][Full Text] [Related]
11. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder. Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732 [TBL] [Abstract][Full Text] [Related]
12. [Expression of Fas ligand in urogenital malignant cell lines and renal cell carcinoma]. Li H; Yu L; Guo Y; Ding Y; Liu L Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):201-3. PubMed ID: 11832029 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562 [TBL] [Abstract][Full Text] [Related]
14. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder]. Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150 [TBL] [Abstract][Full Text] [Related]
15. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154. Loskog A; Tötterman TH; Böhle A; Brandau S Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel. Grim J; D'Amico A; Frizelle S; Zhou J; Kratzke RA; Curiel DT Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2415-23. PubMed ID: 9815642 [TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ. Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411 [TBL] [Abstract][Full Text] [Related]
18. [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report]. Takada T; Honda M; Momohara C; Komori K; Fujioka H Hinyokika Kiyo; 2002 Apr; 48(4):239-42. PubMed ID: 12048939 [TBL] [Abstract][Full Text] [Related]
19. [Deletion of MTS1/p16 gene in human esophageal carcinoma]. Jin S; Peng Q; Lu S Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):9-11. PubMed ID: 10921045 [TBL] [Abstract][Full Text] [Related]
20. [Multiple inhibitory mechanisms of wild-type p16 gene transfer into human bladder cells by retroviral vector]. Wu Y; Ma T; Wu H; Zhang W; Wu C Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):456-8. PubMed ID: 11829887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]